This company listing is no longer active
Neovasc Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Información clave
24.0%
Tasa de crecimiento de los beneficios
101.8%
Tasa de crecimiento del BPA
| Crecimiento de la industria Medical Equipment | 4.3% |
| Tasa de crecimiento de los ingresos | -4.3% |
| Rentabilidad financiera | -260.1% |
| Margen neto | -1,082.9% |
| Última actualización de beneficios | 31 Dec 2022 |
Actualizaciones de resultados anteriores recientes
Recent updates
Desglose de ingresos y gastos
Cómo gana y gasta dinero Neovasc. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 22 | 4 | -41 | 19 | 18 |
| 30 Sep 22 | 3 | -34 | 13 | 15 |
| 30 Jun 22 | 3 | -33 | 14 | 15 |
| 31 Mar 22 | 3 | -33 | 14 | 14 |
| 31 Dec 21 | 3 | -25 | 16 | 15 |
| 30 Sep 21 | 2 | -23 | 17 | 18 |
| 30 Jun 21 | 2 | -26 | 19 | 20 |
| 31 Mar 21 | 2 | -27 | 19 | 20 |
| 31 Dec 20 | 2 | -29 | 16 | 20 |
| 30 Sep 20 | 2 | -37 | 16 | 21 |
| 30 Jun 20 | 2 | -33 | 13 | 21 |
| 31 Mar 20 | 2 | -31 | 12 | 20 |
| 31 Dec 19 | 2 | -35 | 12 | 20 |
| 30 Sep 19 | 2 | -11 | 14 | 18 |
| 30 Jun 19 | 2 | -20 | 18 | 17 |
| 31 Mar 19 | 2 | -61 | 17 | 16 |
| 31 Dec 18 | 2 | -108 | 16 | 16 |
| 30 Sep 18 | 2 | -125 | 19 | 15 |
| 30 Jun 18 | 3 | -115 | 14 | 16 |
| 31 Mar 18 | 4 | -71 | 14 | 16 |
| 31 Dec 17 | 5 | -22 | 14 | 16 |
| 30 Sep 17 | 7 | 19 | 7 | 19 |
| 30 Jun 17 | 9 | -5 | 7 | 19 |
| 31 Mar 17 | 9 | -83 | 7 | 20 |
| 31 Dec 16 | 10 | -86 | 7 | 19 |
| 30 Sep 16 | 9 | -131 | 7 | 19 |
| 30 Jun 16 | 8 | -110 | 7 | 19 |
Ingresos de calidad: G5Z is currently unprofitable.
Margen de beneficios creciente: G5Z is currently unprofitable.
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: G5Z is unprofitable, but has reduced losses over the past 5 years at a rate of 24% per year.
Acelerando crecimiento: Unable to compare G5Z's earnings growth over the past year to its 5-year average as it is currently unprofitable
Beneficios vs. Industria: G5Z is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-26.9%).
Rentabilidad financiera
Alta ROE: G5Z has a negative Return on Equity (-260.14%), as it is currently unprofitable.